Merck & Co., Inc. (MRK) Stock Price, Graph, News & Analysis

Health Technology (Pharmaceuticals: Major) | New York Stock Exchange : MRK

$82.90 -$0.25 (-0.3%)

Market Status : Closed
Last Update : 9/25/2020 3:59:51 PM

MRK

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the foll Read More

Historical Price Graph

Performance

1 Month 3 Month 6 Month YTD 1 Year 3 Year 5 Year
-2.95% 8.59% 21.89% -9.66% 0.06% 24.21% 28.53%

Details

Exchange
New York Stock Exchange

Industry
Pharmaceuticals: Major

Website
http://www.merck.com

Sector
Health Technology

CEO
Kenneth C. Frazier

Total Employees
71,000

SIC Code
2834

Market Cap
$ 209.67 B

Key Statistics

Dividend Rate
$2.38

Last Dividend
2020-09-14

Dividend Yield
2.86%

P/E Ratio
20.11

Price Range (52 Week)
$65.25 - $92.64

Latest Volume
$ 0.00

Average Total Volume
$ 8.05 M

Outstanding Shares
2,529,240,000

Beta
70.61%

Similar Stocks

CompanySectorLatest PriceChange
The Coca-Cola Co. (KO) Consumer Non-Durables $48.73 $0.03
iShares Core S&P 500 ETF (IVV) Miscellaneous $329.95 $5.35
Bank of America Corp. (BAC) Finance $23.51 $0.17
Pfizer Inc. (PFE) Health Technology $36.06 $0.30
AT&T, Inc. (T) Communications $28.05 $0.01

Merck & Co., Inc. in News

Seeking Alpha (MRK)
Merck (MRK) Presents at ESMO Virtual Congress - Slideshow (NYSE:MRK) The following slide deck was published by Merck & Co., Inc. in conjunction with this event..
Sep 25, 2020 1:48 PM

Finanzen CH (MRK)
AstraZeneca und Merck & Co bekommen zwei Empfehlungen für Lynparza - Aktien schwächer Der Ausschuss für Humanarzneimittel der Europäischen Arzneimittelagentur empfahl am Montag die Zulas
Sep 22, 2020 11:33 AM

Finanzen CH (MRK)
AstraZeneca und Merck & Co bekommen zwei Empfehlungen für Lynparza - AstraZeneca-Aktie freundlich Der Ausschuss für Humanarzneimittel der Europäischen Arzneimittelagentur empfahl am Montag die Zulas
Sep 22, 2020 3:44 AM

Business Wire (MRK)
Mercks KEYTRUDA® (pembrolizumab) Plus Chemotherapy Reduced Risk of Death by 27% Versus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Esophageal Cancer KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--KEYTRUDA Plus Chemotherapy Reduced Risk of Death by
Sep 21, 2020 12:30 PM

Business Insider (MRK)
Inside Big Pharma's work with celebs Summary List Placement Hello, Welcome back to the workweek. I, for one, have never been less excited
Sep 21, 2020 9:02 AM

Seeking Alpha (MRK)
Mercks Keytruda delays recurrence and distant metastasis vs. placebo in skin cancer (NYSE:MRK) Merck (NYSE:MRK) and the European Organisation for Research and Treatment of Cancer (EORTC) announce
Sep 21, 2020 8:06 AM

Seeking Alpha (MRK)
AstraZeneca, Merck Lynparza shows positive action in late-stage prostate cancer study (NYSE:AZN) AstraZeneca (NYSE:AZN) and Merck (NYSE:MRK) announce final results from the Phase III PROfound trial
Sep 21, 2020 3:06 AM

Business Wire (MRK)
LYNPARZA® (olaparib) Reduced the Risk of Death by 31% in BRCA1/2 or ATM-mutated Metastatic Castration-Resistant Prostate Cancer in Phase III Profound Trial WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Merck (NYSE: MRK), known as MSD outside the Unite
Sep 20, 2020 12:30 PM

Business Wire (MRK)
Merck and Eisai Present First-Time Data From Two Studies Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Seven Different Tumor Types at ESMO Virtual Congress 2020 KENILWORTH, N.J., & WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck and Eisai Present Fir
Sep 20, 2020 8:25 AM

Business Wire (MRK)
Mercks KEYTRUDA® (pembrolizumab) Reduced the Risk of Distant Metastasis or Death by 40% Versus Placebo as Adjuvant Treatment in Resected, High-Risk Stage III Melanoma KENILWORTH, N.J., & BRUSSELS--(BUSINESS WIRE)---- $MRK #MRK--Mercks KEYTRUDA Reduced the Risk of Di
Sep 19, 2020 10:20 AM

Common Questions Related to Merck & Co., Inc.

When is Merck & Co., Inc. next earning date?

Merck & Co., Inc. next earning date is 2020-10-27

What is dividend yield of Merck & Co., Inc. stock?

Merck & Co., Inc. dividend yield is 0.028622970535177386 and Merck & Co., Inc. announced last dividend in 2020-09-14 of amount $2.38/stock.

What is Merck & Co., Inc. stock symbol?

Merck & Co., Inc. traded in New York Stock Exchange stock exchange and the stock symbol/ticker is MRK

What is the latest share price of Merck & Co., Inc. (MRK)? or What is Merck & Co., Inc. stock price today?

Merck & Co., Inc. latest stock price is $82.90

Where is Merck & Co., Inc. headquarter?

Merck & Co., Inc. headquarter is at – 2000 Galloping Hill Road, Kenilworth, NJ, US

What is the total market cap of Merck & Co., Inc. company?

The total market value of Merck & Co., Inc. stock is $ 210.31 B

What is the P/E ratio of Merck & Co., Inc. stock?

Merck & Co., Inc. P/E ratio is 20.11

What is the EPS of Merck & Co., Inc. stock?

Merck & Co., Inc. EPS is 4.1233

What is the Beta of Merck & Co., Inc. stock?

Merck & Co., Inc. Beta is 0.7061344025548407